Diosmin, a citrus fruit-derived phlebotonic bioflavonoid protects rats from chronic kidney disease-induced loss of bone mass and strength without deteriorating the renal function-Reference-Cited by-同舟云学术

Diosmin, a citrus fruit-derived phlebotonic bioflavonoid protects rats from chronic kidney disease-induced loss of bone mass and strength without deteriorating the renal function

Published:2022 Issue:4 Volume:13 Page:2184-2199
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Sharma Shivani¹²,Porwal Konica¹,Kulkarni Chirag¹²,Pal Subhashis¹,Sihota Praveer³,Kumar Saroj³,Tiwari Mahesh Chandra¹,Katekar Roshan⁴²,Kumar Ashish⁴^ORCID,Singh Priya¹,Rajput Swati¹²,Guha Rajdeep⁵^ORCID,Kumar Navin³,Gayen Jiaur R.⁴^ORCID,Chattopadhyay Naibedya¹²^ORCID

Affiliation:

1. Division of Endocrinology and Centre for Research in ASTHI, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow, 226031, India

2. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India

3. Department of Mechanical Engineering, Indian Institute of Technology Ropar, Rupnagar, Punjab, 140001, India

4. Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow, 226031, India

5. Division of Laboratory Animal Facility, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow, 226031, India

Abstract

Kidney Disease Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline has recommended treatment decisions for patients with chronic kidney disease (CKD) with osteoporosis and/or high risk of fracture.

Funder

Council of Scientific and Industrial Research, India

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/FO/D1FO03867B

Reference82 articles.

1. Management of Osteoporosis in CKD

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives

3. Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease